DirkJan Hijnen
Erasmus Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name DirkJan Hijnen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:59 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06512753 · The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical Care: a Patient Preference TrialErasmus Medical Center · unknown · Lichen Planopilaris, Cicatricial Alopecia · principal investigator
- N/ANCT06512766 · a Retrospective Study on the Systemic Treatment of LPP and FFAErasmus Medical Center · completed · Cicatricial Alopecia, Lichen Planopilaris, Lichen Plano-Pilaris · principal investigator
- Ph4NCT06004986 · DUPIlumab Dose REDUCtion in Patients With Controlled Atopic EczemaAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · active not recruiting · Atopic Dermatitis, Atopic Dermatitis Eczema · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:59 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.Allergy · 2005259 citationsRCR 6.1
- 254 citationsRCR 19.2
- PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation.J Clin Invest · 2018102 citationsRCR 3.1
- 35 citationsRCR 6.8
- Modulation of lymphocyte function in vivo via inhibition of calcineurin or purine synthesis in patients with atopic dermatitis.J Invest Dermatol · 20124 citationsRCR 0.1